Farmacogenética da varfarina : proposta de um algoritmo para a predição de dose
DOI:
关键词:
摘要:
参考文章(98)
RR Meehan, JR Gosden, Rout D, ND Hastie, T Friedberg, M Adesnik, R Buckland, V Van Heyningen, J Fletcher, NK Spurr, J Sweeney, CR Wolf, Human cytochrome P-450 PB-1: a multigene family involved in mephenytoin and steroid oxidations that maps to chromosome 10. American Journal of Human Genetics. ,vol. 42, pp. 26- 37 ,(1988)
Farhad Kamali, H. Wynne, P. Kelly, C. Edwards, T. Whittingham, L. Cope, The influence of age, liver size and enantiomer concentrations on warfarin requirements. British Journal of Clinical Pharmacology. ,vol. 40, pp. 203- 207 ,(1995)
Richard L Slaughter, David J Edwards, Recent advances: the cytochrome P450 enzymes. Annals of Pharmacotherapy. ,vol. 29, pp. 619- 624 ,(1995) , 10.1177/106002809502900612
O Gotoh, Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. Journal of Biological Chemistry. ,vol. 267, pp. 83- 90 ,(1992) , 10.1016/S0021-9258(18)48462-1
TE Klein, RB Altman, Niclas Eriksson, BF Gage, SE Kimmel, MT Lee, NA Limdi, D Page, DM Roden, MJ Wagner, MD Caldwell, JA Johnson, YT Chen, MS Wen, Y Caraco, I Achache, S Blotnick, M Muszkat, JG Shin, HS Kim, G Suarez-Kurtz, JA Perini, E Silva-Assuncao, JL Anderson, BD Horne, JF Carlquist, RL Berg, JK Burmester, BC Goh, SC Lee, F Kamali, E Sconce, AK Daly, AH Wu, TY Langaee, H Feng, L Cavallari, K Momary, M Pirmohamed, A Jorgensen, CH Toh, P Williamson, H McLeod, JP Evans, KE Weck, C Brensinger, Y Nakamura, T Mushiroda, D Veenstra, L Meckley, MJ Rieder, AE Rettie, M Wadelius, H Melhus, CM Stein, U Schwartz, D Kurnik, E Deych, P Lenzini, C Eby, LY Chen, P Deloukas, A Motsinger-Reif, H Sagreiya, BS Srinivasan, E Lantz, T Chang, M Ritchie, LS Lu, Estimation of the warfarin dose with clinical and pharmacogenetic data The New England Journal of Medicine. ,vol. 360, pp. 753- 764 ,(2009) , 10.1056/NEJMOA0809329
Mark W. Linder, Stephen Looney, Jesse E. Adams III, Nancy Johnson, Deborah Antonino-Green, Nichole Lacefield, Bonny L. Bukaveckas, Roland Valdes Jr, Warfarin dose adjustments based on CYP2C9 genetic polymorphisms. Journal of Thrombosis and Thrombolysis. ,vol. 14, pp. 227- 232 ,(2002) , 10.1023/A:1025052827305
Janis Taube, David Halsall, Trevor Baglin, Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment. Blood. ,vol. 96, pp. 1816- 1819 ,(2000) , 10.1182/BLOOD.V96.5.1816
A. Oates, P. R. Jackson, C. A. Austin, K. S. Channer, A new regimen for starting warfarin therapy in out-patients British Journal of Clinical Pharmacology. ,vol. 46, pp. 157- 161 ,(1998) , 10.1046/J.1365-2125.1998.00755.X
M. B. Faletto, J. A. Goldstein, L. S. Kaminsky, S. M. F. De Morais, D. A. Dunbar, Correlation of human cytochrome P4502C substrate specificities with primary structure : warfarin as a probe Molecular Pharmacology. ,vol. 43, pp. 234- 239 ,(1993)
Csilla Sipeky, Béla Melegh, Haplogroup analysis of vitamin-K epoxide reductase (VKORC1) gene: novel element in the optimization of anticoagulant therapy Orvosi Hetilap. ,vol. 149, pp. 1839- 1844 ,(2008) , 10.1556/OH.2008.28456